SCHEMBL7964803

SCHEMBL7964803

c1ccc(-c2cccc(-c3cccc(-c4ccccn4)n3)n2)nc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 1.00
TP53 P04637 4/20 1.00
ALOX15 P16050 4/20 1.00
L3MBTL1 Q9Y468 4/20 1.00
SMN1; SMN2 Q16637 4/20 1.00
CCR1 P32246 3/20 1.00
CCR5 P51681 3/20 1.00
CCR8 P51685 3/20 1.00
LMNA P02545 3/20 1.00
TDP1 Q9NUW8 3/20 1.00
HTT P42858 2/20 1.00
ALPL P05186 2/20 1.00
HSP90AA1 P07900 1/20 1.00
ALPI P09923 1/20 1.00
ALPG P10696 1/20 1.00
MAPK1 P28482 1/20 1.00
CYP1A2 P05177 2/20 0.78
POLB P06746 1/20 0.78
METAP1 P53582 1/20 0.78
BLM P54132 1/20 0.78

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Terpyridine SCHEMBL29357603 1.00 KDM4E (1.00) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
SCHEMBL30172832 1.00 KDM4E (1.00) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL57442 1.00 KDM4E (1.00) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL31621745 0.97 KDM4E (0.95) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL7112915 0.97 KDM4E (0.95) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL3150051 0.97 KDM4E (0.95) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL2953496 0.97 KDM4E (0.95) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL1616654 0.97 KDM4E (0.95) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL8536195 0.97 KDM4E (0.95) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2
Terpyridine SCHEMBL5899140 0.97 KDM4E (0.95) KDM4ETP53ALOX15L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025087626-A1 PHOTO-ELECTROCHEMICAL DEVICE UNIVERSITE PARIS CITE (FR) 2025-05-01 WO disclosed
EP-4545682-A1 PHOTO-ELECTROCHEMICAL DEVICE Université Paris Cité (FR) 2025-04-30 EP disclosed
US-20240209020-A1 REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) 2024-06-27 US disclosed
CN-117747414-B Method for cleaning semiconductor wafer substrate 中国科学院长春光学精密机械与物理研究所 2024-04-23 CN disclosed
CN-117747414-A Method for cleaning semiconductor wafer substrate 中国科学院长春光学精密机械与物理研究所 2024-03-22 CN disclosed
US-11706938-B2 Photoelectric conversion element and photoelectric conversion module RICOH COMPANY, LTD. (JP) 2023-07-18 US disclosed
US-11706938-B2 Photoelectric conversion element and photoelectric conversion module RICOH COMPANY, LTD. (JP) 2023-07-18 US disclosed
EP-3786151-B1 METHOD FOR PRODUCING AMIDE COMPOUND CHUBU UNIV EDUCATIONAL FOUNDATION (JP) 2023-06-07 EP disclosed
US-20230171975-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, ELECTRONIC DEVICE, AND PARTITION RICOH COMPANY, LTD., (JP) 2023-06-01 US disclosed
US-20230171975-A1 PHOTOELECTRIC CONVERSION ELEMENT, PHOTOELECTRIC CONVERSION MODULE, ELECTRONIC DEVICE, AND PARTITION RICOH COMPANY, LTD., (JP) 2023-06-01 US disclosed
US-20100101643-A1 COMPOUND, PHOTOELECTRIC CONVERTER AND PHOTOELECTROCHEMICAL CELL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-29 US disclosed
US-20100091352-A1 DISPLAY ELEMENT AND DRIVING METHOD THEREOF KONICA MINOLTA HOLDINGS, INC. (JP) 2010-04-15 US disclosed
US-20100091352-A1 DISPLAY ELEMENT AND DRIVING METHOD THEREOF KONICA MINOLTA HOLDINGS, INC. (JP) 2010-04-15 US disclosed
US-20100004443-A1 LINEAR PYRIDAZINE AND PYRROLE COMPOUNDS, METHOD FOR OBTAINING THEM AND APPLICATIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N. (FR) 2010-01-07 US disclosed
US-20100004443-A1 LINEAR PYRIDAZINE AND PYRROLE COMPOUNDS, METHOD FOR OBTAINING THEM AND APPLICATIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N. (FR) 2010-01-07 US disclosed
WO-2008012441-A2 LINEAR PYRIDAZINE AND PYRROLE COMPOUNDS, PROCESSES FOR OBTAINING THEM AND USES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2008-01-31 WO disclosed
WO-2008012440-A2 PYRIDAZINE AND PYRROLE COMPOUNDS, PROCESSES FOR OBTAINING THEM AND USES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) 2008-01-31 WO disclosed
US-6187928-B1 TREATING FUNGAL DISEASES THE ROCKEFELLER UNIVERSITY 2001-02-13 US disclosed
US-6087510-A Method of use of imidazolium cations THE ROCKEFELLER UNIVERSITY (US) 2000-07-11 US disclosed
US-5874587-A FLUORESCENCE THE ROCKEFELLER UNIVERSITY (US) 1999-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004443-A1 LINEAR PYRIDAZINE AND PYRROLE COMPOUNDS, METHOD FOR OBTAINING THEM AND APPLICATIONS PPOX, PNPO, PLPBP KDM4E 2135/4885TP53 908/4885ALOX15 236/4885
US-20100101643-A1 COMPOUND, PHOTOELECTRIC CONVERTER AND PHOTOELECTROCHEMICAL CELL CRY1, CRY2, CCNA1 KDM4E 1480/4885TP53 2858/4885ALOX15 3322/4885
US-20240209020-A1 REACTION AGENT FOR AMIDE REACTION AND METHOD FOR PRODUCING AMIDE COMPOUND USING SAME NAAA, FAAH, FAAH2 KDM4E 2342/4885TP53 3067/4885ALOX15 294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.